Early increase of oxidative stress and reduced antioxidant defenses in patients with uncomplicated type 1 diabetes: A case for gender difference

Diabetes Care

Volumn 25, Issue 2, 2002, Pages 370-375

  Marra, Giampiero ^a   Cotroneo, Patrizia ^a   Pitocco, Dario ^a   Manto, Andrea ^a   Di Leo, Mauro A S ^a   Ruotolo, Valeria ^a   Caputo, Salvatore ^a   Giardina, Bruno ^a   Ghirlanda, Giovanni ^a,b   Santini, Stefano A ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b CATHOLIC UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALKADIENE; ANTIOXIDANT; LIPID HYDROPEROXIDE; URIC ACID; LIPID PEROXIDE;

ANTIOXIDANT ACTIVITY; ARTICLE; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; ISCHEMIC HEART DISEASE; MALE; OXIDATIVE STRESS; SEX DIFFERENCE; ADULT; COMPARATIVE STUDY; CORONARY ARTERY DISEASE; METABOLISM; RISK FACTOR; SEXUAL DEVELOPMENT;

ADULT; ANTIOXIDANTS; CORONARY DISEASE; DIABETES MELLITUS, TYPE 1; FEMALE; HUMANS; LIPID PEROXIDES; MALE; OXIDATIVE STRESS; RISK FACTORS; SEX CHARACTERISTICS;

EID: 0036481698     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.25.2.370     Document Type: Article

References (46)

1. Harris MI, Hadden WC, Knowler WC, Bennett PH: Prevalence of diabetes and impaired glucose tolerance and plasma glucose levels in U.S. population aged 20-74 yr. Diabetes 36:523-534, 1987
2. Haffner SM, Letho S, Ronnamaa T, Pyorala K, Laakso M: Coronary heart disease mortality in subjects with type 2 diabetes and in non diabetic subjects with and without previous myocardial infarction. N Engl J Med 339:229-234, 1998
3. Laing SP, Swedlow AJ, Slater DS, Botha JL, Burden AC, Waugh NR, Smith AW, Hill RD, Bingley PJ, Patterson CC. Qiao Z, Keen H: The British Diabetic Association Cohort Study II: cause specific mortality in patients with insulin-treated diabetes mellitus. Diabet Med 16:466-471, 1999
4. Krolewski AS, Kosinnski EJ, Warram JI, Leland OS, Busick EJ, Asmal AC, Rand LI, Christlieb AR, Bradley RF, Kahn CR: The Magnitude and determinants of coronary artery disease in juvenile-onset insulin dependent diabetes. Am J Cardiol 59:750-755, 1987
5. Kannel WB, Wilson PWF: Rish factors that attenuate the female coronary advance. Arch Intern Med 155:57-61, 1995
6. Heyden S, Heiss G, Bartel AG, Hames CG: Sex differences in coronary mortality among diabetics in Evans County, Georgia. J Chron Dis 33:265-273, 1980
7. Gu K, Cowie CC, Harris MI: Diabetes and decline in heart disease mortality in US adults. JAMA 281:1291-1297, 1999
8. Wolff SP: The potential role of oxidative stress in diabetes and its complications: novel implications for theory and therapy. In Diabetic Complications: Scientific and Clinical Aspects. Crabbe MJC, Ed. New York, Churchill-Livingston, 1987, p. 167-220
9. Baynes JW: Role of oxidative stress in development of complications in diabetes. Diabetes 40:405-412, 1991
10. Giugliano D, Ceriello A, Paolisso G: Oxidative stress and diabetic vascular complications. Diabetes Care 19:257-267, 1996
11. Nourooz-Zadeh J, Rahimi A, Tajaddini-Sarmadi J, Tritschler H, Rosen P, Halliwell B, Betteridge DJ: Relationships between plasma measures of oxidative stress and metabolic control in non-insulin dependent diabetes mellitus. Diabetologia 40:647-653, 1997
12. Haffner SM, Agil A, Mykkanen L, Stern MP, Jialal L: Plasma oxidizability in subjects with normal glucose tolerance, impaired glucose tolerance and NIDDM. Diabetes Care 18:646-652, 1995
13. Wiztum JL, Steinberg D: Role of oxidized low density lipoprotein in atherogenesis. J Clin Invest 88:1785-1792, 1991
14. Dominguez C, Ruiz E, Gussinye M, Carrascosa A: Oxidative stress at onset and in early stages of type 1 diabetes in children and adolescents. Diabetes Care 21:1736-1742, 1998
15. Santini SA, Marra G, Giardina B, Cotroneo P, Mordente A, Martorana GE, Manto A, Ghirlanda G: Defective plasma antioxidant defenses and enhanced susceptibility to lipid peroxidation in uncomplicated IDDM. Diabetes 46:1853-1858, 1997
16. Stephensen J, Fuller JH for the EURODIAB Complications Study Group. Microvascular and acute complications in IDDM patients: the EURODIAB IDDM Complications Study. Diabetologia 37:278-285, 1994
17. Rice-Evans C, Miller NJ: Total antioxidant status in plasma and body fluids. Methods Enzymol 234:279-293, 1994;
18. Folch J, Lees M, Sloane Stanley GH: A simple method for isolation and purification of total lipids from animal tissues. J Biol Chem 226:497-509, 1957
19. Corongiu FP, Banni S: Detection of conjugated dienes by second derivative ultraviolet spectrophotometry. Methods Enzymol 233:303-310, 1994
20. Sergent O, Morel I, Cogrel P, Chevanne M, Pasdeloup N, Brissot P, Lescoat G, Cillard P, Cillard J: Simultaneous measurements of conjugated dienes and free malondialdehyde, used as micromethod for evaluation of lipid proxidation in rat hepatocyte cultures. Chem Phys Lipids 65:133-139, 1993
21. O'Haver TC: Potential clinical applications of derivative and wavelength-modulation spectrometry. Clin Chem 25:1548-1553, 1979
22. Situnayake RD, Crump BJ, Zezulka AV, Davis M, McConkey B, Thurnham DI: Measurement of conjugated diene lipids by derivative spectroscopy in heptane extracts of plasma. Ann Clin Biochem 27:258-266, 1990
23. Nourooz-Zadeh J, Tajaddini-Sarmadi J, Wolff SP: Measurement of plasma hydroperoxide concentrations by the ferrous oxidatio-xylenol orange assay in conjunction with triphenylphosphine. Anal Biochem 220:403-409, 1994
24. Nourooz-Zadeh J, Tajaddini-Sarmadi J, McCarthy S, Betteridge DJ, Wolff SP: Elevated levels of authentic plasma hydroperoxides in NIDDM. Diabetes 44:1054-1058, 1995
25. Ceriello A, Bortolotti N, Motz E, Crescentini A, Lizzio S, Russo A, Tonutti L, Taboga C: Meal-generated oxidative stress in type 2 diabetic patients. Diabetes Care 21:1529-1533, 1998
26. Berg TJ, Nourooz-Zadeh J, Wolff SP, Tritschler H, Bangstad HJ, Hanssen KF: Hydroperoxides in plasma are reduced by intensified insulin treatment. Diabetes Care 21:1295-1298, 1998
27. Khaw K-T, Wareham N, Luben R, Bingham S, Oakes S, Welch A, Day N: Glycated haemoglobin, diabetes, and mortality in men in Norfolk cohort of European Prospective Investigation of Cancer and Nutrition (EPIC-Norfolk). BMJ 322:1-6, 2001
28. Herman JB, Goldburt U: Uric acid and diabetes: observations in a population study. Lancet II: 240-244, 1982
29. Modan M, Halkin H, Karasik A, Lusky A: Elevated serum uric acid: a facet of hyperinsulinaemia. Diabetologia 30:713-718, 1987
30. Ames BN, Cathcart E, Schwiers E, Hochstein P: Uric acid provides an antioxidant defense in humans against oxidant- and radical-caused aging and cancer: a hypothesis. Proc Natl Acad Sci U S A 78:6858-6862, 1981
31. Becker BF: Towards the physiological function of uric acid. Free Radic Biol Med 14:615-631, 1993
32. Erdberg A, Boner G, Van Dyk DJ, Carel R: Urine uric acid excretion in patients with insulin-dependent diabetes mellitus. Nephron 60:134-137, 1992
33. Gonzalez-Sicilia L, Garcia-Estan J, Martinez-Blazquez A, Fernandez-Pardo J, Quiles JL, Hernandez J: Renal metabolism of uric acid in type 1 insulin-dependent diabetic patients: relation to metabolic compensation. Horm Metab Res 29:520-523, 1997
34. Cotroneo P, Manto A, Todaro L, Manto A Jr, Pitocco D, Saponara C, Vellante C, Maussier ML, D'Errico G, Magnani P: Hyperfiltration in patients with type 1 diabetes mellitus: a prevalence study. Clin Nephrol 50:214-217, 1998
35. Waring WS, Webb DJ, Maxwell SR: Systemic uric acid administration increases serum antioxidant capacity in healthy volunteers. J Cardiovasc Pharmacol 38:365-371, 2001
36. Colhoun HM, Rubens MB, Underwood RS, Fuller JH: The effect of type 1 diabetes mellitus on the gender difference in coronary artery calcification. J Am Coll Cardiol 36:2160-2167, 2000
37. Valabhji J, McColl AJ, Richmond W, Schachter M, Rubens MB, Elkeles RS: Total antioxidant status and coronary artery calcification in type 1 diabetes. Diabetes Care 24:1608-1613, 2001
38. Brussard HE, Gevers Leuven AJ, Kluft C, Krans HMJ, van Duyvenvoorde W, Huytenhek R, van der Laarse A, Prince HMG: Effect of 17 β-estradiol on plasma lipids and LDL oxidation in postmenopausal women with type II diabetes mellitus. Arterioscler Throm Vasc Biol 17:324-330, 1997
39. Cals MJ, Succari M, Meneguzzer E, Ponteziere C, Bories PN, Devanlay M, Desveaux N, Gatey M, Luciani L, Blonde-Cynober F, Coudray-Lucas C: Markers of oxidative stress in fit, health-conscious elderly people living in the Paris area: the Research Group on Ageing. Nutrition 13:319-326, 1997
40. Kim-Schulze S, McGowan KA, Hubchak SC, Cid MC, Martin MB, Kleinman HK, Greene GJ, Schnaper HW: Expression of an estrogen receptor by human coronary artery and umbilical vein endothelial cells. Circulation 94:1402-1407, 1996
41. Lobo RA: Effects of hormonal replacement on lipids and lipoproteins in postmenopausal women. J Clin Endocrinol Metab 73:925-930, 1991
42. Stampfer MJ, Colditz GA, Willett WC, Manson JE, Rosner B, Speizer FE, Hennekens CH: Postmenopausal oestrogen therapy and cardiovascular disease: ten year follow-up from the nurses' health study. N Engl J Med 325:756-762, 1991
43. Steinberg HO, Paradisi G, Cronin J, Crowde K, Hempfling A, Hook G, Baron AD: Type II diabetes abrogates gender differences in endothelial function in premenopausal women. Circulation 101:2040-2046, 2000
44. Grady D, Rubin SM, Petitti DB, Fox CS, Black D, Ettinger B, Ernster VL, Cummings SR: Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann Intern Med 117:1016-1037, 1992
45. Gevers Leuven AJ: Sex steroids and lipoprotein metabolism. Pharmacol Ther 64:99-126, 1994
46. Collins P, Rosano GM, Sarrel PM, Ulrich L, Adamopoulos S, Beale CM, McNeill JG, Poole-Wilson PA: 17 β-Estradiol attenuates acetylcholine- induced coronary artery disease. Circulation 92:24-30, 1995